Wingtech from China demands that Nexperia pay $1.18 billion in court.
Brief overview of the conflict between the Netherlands and Chinese Wingtech
When Dutch authorities gained control over Nexperia – a supplier of automotive semiconductors in Amsterdam, fall 2023. The Chinese parent company Wingtech filed a lawsuit for compensation amounting to $1.18 billion in Guangdong (China) at the end of 2024.
What happened
- The Netherlands, by court decision, obtained full control over Nexperia, a company that manufactures semiconductors for the automotive industry.
- Wingtech, which owns the main Nexperia plants in China, disagreed with this outcome. For it means losing key business and significant losses.
How the parties are responding
Party Actions Wingtech 1) In June 2024 filed a lawsuit in Guangdong against Nexperia and five other companies seeking $1.18 billion in compensation.
2) In January of that year already initiated international arbitration with a claim of $8 billion.
3) Asserts that Dutch measures are discriminatory restrictions causing irreparable damage.
Nexperia reported receiving Wingtech’s statement but emphasized that the case has not yet been heard by a Chinese court.
Netherlands expressed regret over Wingtech’s actions and continues to call for dialogue.
Why China intervened
Chinese authorities agreed to lift export restrictions on Nexperia products outside the country if Wingtech abandons attempts to fully control the business, which it has owned since 2019. This decision was made as part of a settlement to prevent further economic losses.
Financial context
- Last year Wingtech’s net loss tripled to $1.28 billion.
- Under current Chinese legislation on countering foreign sanctions, the company believes it is entitled to compensation for its losses.
Thus, the conflict between the Netherlands and Chinese Wingtech has turned into a legal dispute where both sides demand significant payments from each other. The case is still under review but has already attracted attention from international media and governments.
Comments (0)
Share your thoughts — please be polite and stay on topic.
Log in to comment